布那司特
|
|
- CAS号:
- 99107-52-5
- 英文名:
- 1-Acetoxy-2-butyl-4-methoxynaphtalene
- 英文别名:
- U-66858;Bunaprolast;Bunaprolast (U66858);1-Acetoxy-2-butyl-4-methoxynaphtalene;1-Acetoxy-2-butyl-4-methoxynaphthalene;1-acetoxy-2-n-butyl-4-methoxynaphthalene;1-Naphthalenol, 2-butyl-4-methoxy-, 1-acetate
- 中文名:
- 布那司特
- 中文别名:
- 布那司特;化合物 T17191;BUNAPROLAST (U66858)
- CBNumber:
- CB01075359
- 分子式:
- C17H20O3
- 分子量:
- 272.3389
- MOL File:
- 99107-52-5.mol
|
|
|
布那司特化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
布那司特性质、用途与生产工艺
Bunaprolast (U66858) 是白三烯 B4 (LTB4) 的有效抑制剂。Bunaprolast (U66858) 也抑制脂氧合酶 (lipoxygenase),以及 TXB2 释放。
Bunaprolast (U-66,858) undergoes deacetylation to an initial metabolite with similar pharmacological potency. The inhibitory effects of the semi-quinone Bunaprolast and its metabolite U-68,244 on the ionophore-induced formation of leukotriene B4 (LTB4) are examined in human whole blood (WB). Preincubation of Bunaprolast and U-68,244 for 1 min prior to challenge of blood with calcium ionophore A23187 results in IC
50
s of 1080±644 and 820±442 nM, respectively. After 60 min preincubation, IC
50
s are 250±85 and 270±79 nM. The activity of the lipoxygenase inhibitor AA-861 in this system is similar to that of Bunaprolast, while vitamin K and the sulphate conjugate of Bunaprolast show significant inhibition of LTB4 release only at micromolar concentrations. Bunaprolast exhibits significant inhibition of thromboxane A2 release (p<0.02) in a comparative study with the known cyclooxygenase (CO) inhibitor Flurbiprofen.
The IgE-mediated hypersensitivity to Ascaris antigen in reactor rhesus primates is used to assess the pharmacologic profile of Bunaprolast (U-66,858). When Bunaprolast is given by the oral route, it shows dose-related inhibition of resistance (RL) and compliance (Cdyn) changes. When Bunaprolast is given by the aerosol route, it shows dose independent inhibition. In 15 animals, aerosols (52±32 to 53±10% for RL, p=0.05 and 45±19 to 28±19% Cdyn inhibitions, p=0.05) for 5.0-0.1% aerosol. By the oral route, inhibition is seen at 1-4 h following administration. In 5 animals, oral doses of 10 and 5 mg/kg inhibit (RL by 98±2 to 78±1.5%, p=0.01 and Cdyn by 75±17 to 60.9±9.1%, p=0.05) by 10 and 5 mg/kg Bunaprolast, respectively.
布那司特
上下游产品信息
上游原料
下游产品
99107-52-5, 布那司特 相关搜索:
- 抑制剂
- BUNAPROLAST (U66858)
- 化合物 T17191
- 布那司特
- 99107-52-5
- Bunaprolast (U66858)
- 1-Naphthalenol, 2-butyl-4-methoxy-, 1-acetate
- 1-acetoxy-2-n-butyl-4-methoxynaphthalene
- U-66858
- 1-Acetoxy-2-butyl-4-methoxynaphthalene
- Bunaprolast
- 1-Acetoxy-2-butyl-4-methoxynaphtalene